Joel F. Sussman, Chief Accounting Officer at Galera Therapeutics, Inc. (GRTX), sold 20,000 shares at $10.06 ($204K) on 2020-11-12, disclosed to the SEC on 2020-11-16.
Open-market sale of $204k GRTX by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.06 | 10,000 | $101K | 49.4% |
| 2 | $10.32 | 10,000 | $103K | 50.6% |
| Total | $10.19 avg | 20,000 | $204K | 100% |